Literature DB >> 9512380

Cerebral hemodynamics during electrically induced seizures.

J Vollmer-Haase1, H W Folkerts, C G Haase, M Deppe, E B Ringelstein.   

Abstract

Electroconvulsive therapy (ECT) is an appropriate clinical model to investigate blood flow during seizures. In this study cerebral blood flow velocity (CBFV) was measured during 40 ECTs in 10 patients by means of transcranial Doppler sonography. EEG was recorded continuously. Under general anesthesia, the pre-convulsive blood flow velocity (Vmean) decreased significantly. After ECT, we measured a dramatic increase in Vmean which was significantly greater in the left MCA than in the right MCA. After termination of seizures, flow velocities returned to baseline levels. The striking increase in cerebral blood flow velocity reflects excessive cerebral metabolism during convulsive neuronal activation. The left hemisphere seems to be more sensitive to electrical stimuli as was indicated by its predominant augmentation of CBFVs.

Entities:  

Mesh:

Year:  1998        PMID: 9512380     DOI: 10.1097/00001756-199802160-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

Review 1.  Epilepsy and the consciousness system: transient vegetative state?

Authors:  Hal Blumenfeld
Journal:  Neurol Clin       Date:  2011-11       Impact factor: 3.806

2.  Impaired consciousness in epilepsy.

Authors:  Hal Blumenfeld
Journal:  Lancet Neurol       Date:  2012-09       Impact factor: 44.182

3.  Lateralization of cerebral blood flow in juvenile absence seizures.

Authors:  Semai Bek; Tayfun Kaşikçi; Gençer Genç; Seref Demirkaya; Zeki Gökçil; Zeki Odabaşi
Journal:  J Neurol       Date:  2010-02-13       Impact factor: 4.849

4.  rTMS Therapy Reduces Hypofrontality in Patients With Depression as Measured by fNIRS.

Authors:  Yasuo Kawabata; Shin-Ichi Imazu; Koichi Matsumoto; Katsunori Toyoda; Makoto Kawano; Yoichiro Kubo; Shinya Kinoshita; Yoshitaka Nishizawa; Tetsufumi Kanazawa
Journal:  Front Psychiatry       Date:  2022-06-22       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.